Change in Number of Shares and Votes in Aerocrine
January 30 2015 - 2:34AM
Business Wire
Regulatory News:
Aerocrine (STO:AEROB)
With reference to Chapter 4 Section 9 in ”lagen (1991:980) om
handel med finansiella instrument” it’s hereby announced that
through the subscription by a new share issue related to the
company’s stock option program in Aerocrine the number of shares
and votes in Aerocrine has increased during January 2015 as
specified in the table below. (PLEASE NOTE THAT THE CHANGE IN
NUMBER OF SHARES DUE TO THE ONGOING RIGHTS SHARE ISSUE WILL BE
PUBLISHED ON FEBRUARY 27TH).
Number of shares and votes January 1, 2015 155 063 162
Increase 353 225 January 30, 2015 155 416 387
Solna January 30, 2015
Aerocrine AB (publ.)
About Aerocrine
Aerocrine AB is a medical products company focused on improved
management and care of patients with inflammatory airway diseases
such as Asthma. Within this sector, Aerocrine is the world leader.
Aerocrine markets NIOX MINO® and NIOX VERO®, which enables fast and
reliable point-of-care measurement of airway inflammation. These
products plays a critical role in more effective diagnosis,
treatment and follow-up of patients affected with inflammatory
airway diseases. Aerocrine is based in Sweden with subsidiaries in
the US, Germany, Switzerland and the UK. Aerocrine shares have
been listed on the Stockholm Stock Exchange since 2007 (AERO-B.ST).
For more information please visit www.aerocrine.com and
www.niox.com.
+
------------------------------------------------------------------------------
+ |Aerocrine may be required to disclose the information
provided herein pursuant| |to the Securities Markets Act and/or the
Financial Instruments Trading Act. | |The information was submitted
for publication at 08:00 am on January 30, 2015.| +
------------------------------------------------------------------------------
+
This information was brought to you by Cision
http://news.cision.com
AerocrineMarshall Woodworth, CFO+1 919 749 8748+46 709
695 219